CD4 and HIV-1 infection: The inhibitory activity of silver nanoparticles against the gp120-CD4 interaction was also investigated in a competitive gp120-capture ELISA, which together with the cell-based fusion assay, showed that silver nanoparticles inhibit HIV-1 infection by blocking viral entry, particularly the gp120-CD4 interaction.